Peptides
Les peptides sont des chaînes courtes d'acides aminés liées par des liaisons peptidiques, jouant un rôle essentiel en tant que molécules biologiques dans divers processus cellulaires. Ils fonctionnent comme hormones, neurotransmetteurs et molécules de signalisation, et sont largement utilisés dans les applications thérapeutiques et diagnostiques. Les peptides sont également cruciaux dans la recherche pour étudier les interactions protéiques, les activités enzymatiques et les voies de signalisation cellulaire. Chez CymitQuimica, nous proposons une large sélection de peptides de haute qualité pour soutenir vos besoins en recherche et développement en biotechnologie et en pharmacie.
Sous-catégories appartenant à la catégorie "Peptides"
29613 produits trouvés pour "Peptides"
Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
Kinase Domain of Insulin Receptor (4)
Catalogue peptide; min. 95% purityFormule :C72H108N19O27Masse moléculaire :1,702.77 g/molInterleukin II (60-70)
Catalogue peptide; min. 95% purityFormule :C68H104N14O14SMasse moléculaire :1,373.74 g/molEndothelin-1 (1-15), human
Catalogue peptide; min. 95% purity
Formule :C70H108N16O24S5Masse moléculaire :1,718.02 g/molbeta-Amyloid Protein Precursor (657-676)
Catalogue peptide; min. 95% purity
Formule :C95H152N30O31Masse moléculaire :2,210.45 g/molBiotin-a-CGRP (human)
Catalogue peptide; min. 95% purityFormule :C173H281N53O51S2Masse moléculaire :4,015.69 g/molH-D-Arg(Mtr)-OH
CAS :H-D-Arg(Mtr)-OH is a biochemical that is used for the deprotection of prohormones. H-D-Arg(Mtr)-OH has been shown to have an interaction with peptidyl residues, which modulates their activity. H-D-Arg(Mtr)-OH also modulates the allosteric activity of fibrinogen and thrombin receptor. The use of this chemical in solid phase synthesis provides a way to synthesize peptides on a solid support, such as indole rings, amino acids, or nucleotides. The chemical can be used in the hplc system to determine the concentration of small molecules in solution by measuring the peak area.Formule :C16H26N4O5SDegré de pureté :Min. 95%Masse moléculaire :386.47 g/molbeta-Amyloid (13-27)
Catalogue peptide; min. 95% purityFormule :C84H126N24O24Masse moléculaire :1,856.09 g/molH-Leu-NHOH·TFA
CAS :H-Leu-NHOH·TFA is a histidine analogue that is used as a catalyst. It has been shown to be an effective inhibitor of corynebacteria, and can be used in the synthesis of fatty acids, which are important for cell membrane production. H-Leu-NHOH·TFA also binds to the enzyme synthetase and inhibits its activity, which blocks the conversion of ammonia and amino acids into polypeptides. This inhibition prevents bacterial growth. H-Leu-NHOH·TFA is active at acidic pH levels, with a maximum activity at pH 4.0. The optimum temperature for this compound is 50°C, but it will still work at temperatures up to 60°C.Formule :C6H14N2O2·C2HF3O2Degré de pureté :Min. 95%Couleur et forme :PowderMasse moléculaire :260.21 g/molPreprogalanin 28-67, rat
Catalogue peptide; min. 95% purityFormule :C198H312N62O58Masse moléculaire :4,488.96 g/molBiotin-LC-Protein Kinase G Substrate
Catalogue peptide; min. 95% purityFormule :C69H121N25O18SMasse moléculaire :1,621 g/molCaspase 2 Substrate 1m (ICH-1), fluorogenic
Catalogue peptide; min. 95% purityFormule :C33H44N6O12Masse moléculaire :716.8 g/molGIP, mouse, rat
Catalogue peptide; min. 95% purityFormule :C226H343N61O66SMasse moléculaire :5,002.69 g/molInfluenza NP (50-57)
Catalogue peptide; min. 95% purityFormule :C41H65N11O15Masse moléculaire :952.04 g/molP75-TNFR Fragment
Catalogue peptide; min. 95% purityFormule :C53H85N15O15SMasse moléculaire :1,204.42 g/mol[D-Ala2] Met-Enkephalin
Catalogue peptide; min. 95% purity
Formule :C28H37N5O7SMasse moléculaire :587.70 g/molDynorphin A (8-17), porcine
Catalogue peptide; min. 95% purityFormule :C59H96N18O15Masse moléculaire :1,297.53 g/molBiotin-Somatostatin-14
Catalogue peptide; min. 95% purityFormule :C86H118N20O21S3Masse moléculaire :1,864.21 g/mol[Val671]-Amyloid b/A4 Protein Precursor770 (667-676)
Catalogue peptide; min. 95% purityFormule :C51H82N14O18Masse moléculaire :1,179.31 g/molCDPKS, Syntide analog
Catalogue peptide; min. 95% purityFormule :C47H86N16O13Masse moléculaire :1,083.31 g/molACTH (18-39) (human) (Adrenocorticotropic Hormone) (Biotin)
Catalogue peptide; min. 95% purity
Formule :C122H179N29O38Masse moléculaire :2,659.89 g/mol[D-Ala2]-β-Casomorphin (1-4) amide (bovine)
Catalogue peptide; min. 95% purityFormule :C26H33N5O5Masse moléculaire :495.58 g/molRSK Substrate, S6 (231-239)
Catalogue peptide; min. 95% purityFormule :C45H88N22O11Masse moléculaire :1,113.34 g/molbeta-Endorphin (1-26), human
Catalogue peptide; min. 95% purityFormule :C130H208N32O38SMasse moléculaire :2,859.36 g/molα-Conotoxin MI
Catalogue peptide; min. 95% purityFormule :C58H92N22O17S4Masse moléculaire :1,497.74 g/molAtrial Natriuretic Factor (4-28) (human)
Catalogue peptide; min. 95% purityFormule :C112H175N39O35S3Masse moléculaire :2,724.02 g/molR-G-D-S-P-A-S-S-K-P
Catalogue peptide; min. 95% purityFormule :C40H68N14O16Masse moléculaire :1,001.07 g/molKinase Domain of Pyruvate Kinase, porcine liver
Catalogue peptide; min. 95% purityFormule :C32H62N12O13PMasse moléculaire :853.88 g/molGastrin-1, human
Catalogue peptide; min. 95% purityFormule :C97H125N20O31SMasse moléculaire :2,098.22 g/mol[Lys4] Sarafotoxin S6c
Catalogue peptide; min. 95% purityFormule :C105H153N27O36S5Masse moléculaire :2,529.87 g/molMMP Biotinylated Substrate I
Catalogue peptide; min. 95% purityFormule :C53H86N14O11Masse moléculaire :1,127.43 g/mol[Tyr1]-δ-Sleep Inducing Peptide
Catalogue peptide; min. 95% purityFormule :C33H47N9O16Masse moléculaire :825.79 g/molProdynorphin (228-256), porcine
Catalogue peptide; min. 95% purityFormule :C161H236N42O48Masse moléculaire :3,527.93 g/molMyristoylated Protein Kinase C (19-31)
Catalogue peptide; min. 95% purityFormule :C81H144N26O26Masse moléculaire :1,754.23 g/molα-Helical CRF (9-41)
Catalogue peptide; min. 95% purityFormule :C166H274N46O53S2Masse moléculaire :3,826.44 g/mola2b1Integrin Recognition Sequence
CAS :a2b1Integrin Recognition Sequence is a chemotherapeutic drug that is used in experimental models of hyperproliferative diseases, such as cancer. It activates α subunit of integrins, which are expressed on cells and mediate the adhesion to extracellular matrix proteins. The drug binds to integrin receptors on the surface of tubule cells and promotes their death by apoptosis. This protein stabilizes hydrogen bonding interactions between two or more molecules that are present at a site of chemical reaction, thus inhibiting cellular proliferation and tumor growth. As a result, a2b1Integrin Recognition Sequence inhibits the proliferation of human serum albumin (HSA) and basic fibroblast growth factor (bFGF), which are cell culture models for α subunit-integrin receptor interactions. Analysis of the structure of this protein reveals an integrin recognition sequence motif with three invariant residues: Arg-Gly-Asp (RGD).Formule :C14H22N4O9Degré de pureté :Min. 95%Masse moléculaire :390.35 g/molFmoc-D-Ser(BSi)-OH
CAS :Please enquire for more information about Fmoc-D-Ser(BSi)-OH including the price, delivery time and more detailed product information at the technical inquiry form on this page
Formule :C24H31NO5SiDegré de pureté :Min. 95%Masse moléculaire :441.59 g/molACV trifluoroacetate salt
CAS :ACV trifluoroacetate salt H-Aad (Cys-D-Val-OH)-OH trifluoroacetate salt is a nonheme iron that has been shown to be an oxidizing agent. It is used in the synthesis of antibiotics and other organic compounds. ACV trifluoroacetate salt H-Aad (Cys-D-Val-OH)-OH trifluoroacetate salt also has synthetase activity, which catalyzes the formation of a thiolate ligand from two molecules of acetyl coenzyme A (ACCOA) and one molecule of propionyl coenzyme A (PCCOA). This ligand binds to metal ions such as Fe2+, which are then reduced to Fe3+ by the metal cluster. The water ligands on the coordination sphere may be replaced by other ligands, such as lysine.Formule :C14H25N3O6SDegré de pureté :Min. 95%Masse moléculaire :363.43 g/molMinigastrin I (human)
Catalogue peptide; min. 95% purity
Formule :C74H99N15O26SMasse moléculaire :1,645.66 g/mol[D-Ala2,DPro4,Tyr5]-β-Casomorphin (1-5), amide
Catalogue peptide; min. 95% purityFormule :C35H42N6O7Masse moléculaire :658.8 g/molbeta-Casomorphin, human
Catalogue peptide; min. 95% purityFormule :C44H61N7O11Masse moléculaire :864.02 g/molWRW4
CAS :Please enquire for more information about WRW4 including the price, delivery time and more detailed product information at the technical inquiry form on this pageFormule :C61H65N15O6Degré de pureté :Min. 95%Masse moléculaire :1,104.27 g/molUremic Pentapeptide (U5-Peptide)
Catalogue peptide; min. 95% purityFormule :C32H48N8O9Masse moléculaire :688.8 g/mol[Tyr22]-a-CGRP (22-37), rat
Catalogue peptide; min. 95% purityFormule :C82H120N20O25Masse moléculaire :1,785.99 g/molIGF-I (1-3)
CAS :IGF-I (1-3) H-Gly-Pro-Glu-OH is a synthetic peptide that has been shown to be effective in treating neuronal death caused by glutamate. It binds to calcium ions and inhibits the activity of gamma-aminobutyric acid, which is an inhibitory neurotransmitter. IGF-I (1-3) H-Gly-Pro-Glu-OH also blocks fatty acid synthesis, leading to necrotic cell death. In vitro assays have shown that this drug can protect against blood group O erythrocytes from pyridoxal phosphate oxidation and protocatechuic acid binding. This drug has also been shown to increase locomotor activity in mice, as well as improve motor function in rats with experimental stroke. IGF-I (1-3) H-Gly-Pro-Glu-OH is synthesized using a polymerase chain reaction technique and consists of amino acids 1 through 3 ofFormule :C12H19N3O6Degré de pureté :Min. 95%Masse moléculaire :301.3 g/molBAD (103-126), human
Catalogue peptide; min. 95% purityFormule :C131H200N40O38SMasse moléculaire :2,975.36 g/molGlycoprotein Hormone a (32-46) amide
Catalogue peptide; min. 95% purityFormule :C78H128N24O20SMasse moléculaire :1,754.09 g/mol[D-Ala2]-beta-Casomorphin (1-6), bovine
Catalogue peptide; min. 95% purityFormule :C33H42N6O8Masse moléculaire :650.7 g/molβ-Amyloid (16-23)
Catalogue peptide; min. 95% purityFormule :C47H69N9O13Masse moléculaire :968.13 g/mol
![[D-Ala2] Met-Enkephalin](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FVAC-00839.webp&w=3840&q=75)
![[Val671]-Amyloid b/A4 Protein Precursor770 (667-676)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FVAC-00712.webp&w=3840&q=75)
![[D-Ala2]-β-Casomorphin (1-4) amide (bovine)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FVAC-00833.webp&w=3840&q=75)
![[Lys4] Sarafotoxin S6c](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FVAC-00293.webp&w=3840&q=75)
![[Tyr1]-δ-Sleep Inducing Peptide](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FVAC-00855.webp&w=3840&q=75)
![[D-Ala2,DPro4,Tyr5]-β-Casomorphin (1-5), amide](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FVAC-00823.webp&w=3840&q=75)
![[Tyr22]-a-CGRP (22-37), rat](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FVAC-00924.webp&w=3840&q=75)
![[D-Ala2]-beta-Casomorphin (1-6), bovine](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FVAC-00830.webp&w=3840&q=75)
